Tag: FDA Tavneos deaths
-
FDA Flags Serious Liver Injury Linked to Tavneos (Avacopan)
Tavneos (avacopan) is a prescription medication approved in 2021 to help treat severe active anti‑neutrophil cytoplasmic autoantibody (ANCA)‑associated vasculitis, a rare autoimmune disease that causes inflammation of small blood vessels. For many patients, Tavneos offered a new option to control a difficult and potentially life‑threatening condition. Now, the U.S. Food and Drug Administration (FDA) says